Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Hamilton BK, Rybicki LA, Li H, Lucas T, Corrigan D, Kalaycio M, Sobecks R, Hanna R, Rotz SJ, Dean RM, Gerds AT, Jagadeesh D, Brunstein C, Sauter CS, Copelan EA, Majhail NS. Hamilton BK, et al. Among authors: sobecks r. Blood Adv. 2023 Aug 22;7(16):4505-4513. doi: 10.1182/bloodadvances.2023010310. Blood Adv. 2023. PMID: 37352262 Free PMC article. Clinical Trial.
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Hamilton BK, Rybicki L, Dean R, Majhail NS, Haddad H, Abounader D, Hanna R, Sobecks R, Duong H, Hill BT, Copelan E, Bolwell B, Kalaycio M. Hamilton BK, et al. Among authors: sobecks r. Am J Hematol. 2015 Feb;90(2):144-8. doi: 10.1002/ajh.23882. Epub 2014 Nov 19. Am J Hematol. 2015. PMID: 25353395 Free article.
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Hamilton BK, Rybicki LA, Grove D, Ferraro C, Starn J, Hodgeman B, Elberson J, Winslow V, Corrigan D, Gerds AT, Hanna R, Kalaycio ME, Sobecks RM, Majhail NS, Dweik RA. Hamilton BK, et al. Among authors: sobecks rm. Blood Adv. 2019 Sep 24;3(18):2732-2737. doi: 10.1182/bloodadvances.2019000345. Blood Adv. 2019. PMID: 31530545 Free PMC article.
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Hill BT, Rybicki LA, Urban TA, Lucena M, Jagadeesh D, Gerds AT, Dean RM, Sobecks RM, Pohlman B, Bolwell B, Kalaycio ME, Hamilton BK, Copelan EA, Majhail NS. Hill BT, et al. Biol Blood Marrow Transplant. 2020 Feb;26(2):262-271. doi: 10.1016/j.bbmt.2019.09.033. Epub 2019 Oct 11. Biol Blood Marrow Transplant. 2020. PMID: 31610237 Free article.
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
Chhabra S, Ahn KW, Hu ZH, Jain S, Assal A, Cerny J, Copelan EA, Daly A, DeFilipp Z, Gadalla SM, Gale RP, Ganguly S, Hamilton BK, Hildebrandt GC, Hsu JW, Inamoto Y, Kanate AS, Khoury HJ, Lazarus HM, Litzow MR, Nathan S, Olsson RF, Pawarode A, Ringden O, Rowe JM, Saad A, Savani BN, Schouten HC, Seo S, Shah NN, Solh M, Stuart RK, Ustun C, Woolfrey AE, Yared JA, Alyea EP, Kalaycio ME, Popat U, Sobecks RM, Saber W. Chhabra S, et al. Among authors: sobecks rm. Blood Adv. 2018 Nov 13;2(21):2922-2936. doi: 10.1182/bloodadvances.2018024844. Blood Adv. 2018. PMID: 30396912 Free PMC article.
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Sweetenham J, Kalaycio M, Copelan E. Mahindra A, et al. Among authors: sobecks r. Br J Haematol. 2009 Aug;146(3):310-6. doi: 10.1111/j.1365-2141.2009.07774.x. Epub 2009 Jun 8. Br J Haematol. 2009. PMID: 19508292 Free article. Clinical Trial.
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.
Dean RM, Pohlman B, Sweetenham JW, Sobecks RM, Kalaycio ME, Smith SD, Copelan EA, Andresen S, Rybicki LA, Curtis J, Bolwell BJ. Dean RM, et al. Br J Haematol. 2010 Jan;148(2):226-34. doi: 10.1111/j.1365-2141.2009.07940.x. Epub 2009 Oct 11. Br J Haematol. 2010. PMID: 19821828 Free article.
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.
Hill BT, Bolwell BJ, Rybicki L, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E. Hill BT, et al. Among authors: sobecks r. Biol Blood Marrow Transplant. 2010 Dec;16(12):1738-46. doi: 10.1016/j.bbmt.2010.06.009. Epub 2010 Jun 14. Biol Blood Marrow Transplant. 2010. PMID: 20558313 Free article.
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Bejanyan N, Bolwell BJ, Lazaryan A, Rybicki L, Tench S, Duong H, Andresen S, Sobecks R, Dean R, Pohlman B, Kalaycio M, Copelan EA. Bejanyan N, et al. Among authors: sobecks r. Biol Blood Marrow Transplant. 2012 Jun;18(6):874-80. doi: 10.1016/j.bbmt.2011.10.032. Epub 2011 Oct 29. Biol Blood Marrow Transplant. 2012. PMID: 22040844 Free article.
190 results